Hilke Zander

3.7k total citations
71 papers, 2.2k citations indexed

About

Hilke Zander is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Hilke Zander has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Hilke Zander's work include Oral microbiology and periodontitis research (10 papers), Dental Trauma and Treatments (8 papers) and Cancer Cells and Metastasis (6 papers). Hilke Zander is often cited by papers focused on Oral microbiology and periodontitis research (10 papers), Dental Trauma and Treatments (8 papers) and Cancer Cells and Metastasis (6 papers). Hilke Zander collaborates with scholars based in United States, Germany and United Kingdom. Hilke Zander's co-authors include Alan M. Polson, Sean W. Meitner, Jakob R. Izbicki, Maximilian Bockhorn, Michael Tachezy, Jack G. Caton, James E. Kennedy, Florian Gebauer, Jens Wærhaug and Vincent F. Lisanti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Hilke Zander

69 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilke Zander United States 26 600 565 560 436 426 71 2.2k
Bjorn Steffensen United States 30 462 0.8× 537 1.0× 661 1.2× 494 1.1× 522 1.2× 66 2.7k
Göran Anneroth Sweden 31 1.1k 1.8× 528 0.9× 479 0.9× 164 0.4× 539 1.3× 100 2.9k
A. T. Cruchley United Kingdom 25 423 0.7× 493 0.9× 567 1.0× 297 0.7× 172 0.4× 38 2.1k
Timothy M. Blieden United States 19 306 0.5× 597 1.1× 430 0.8× 326 0.7× 273 0.6× 28 2.2k
Gisle Bang Norway 23 831 1.4× 210 0.4× 365 0.7× 327 0.8× 263 0.6× 70 2.0k
Nobuyuki Kawashima Japan 23 626 1.0× 322 0.6× 576 1.0× 196 0.4× 103 0.2× 73 1.8k
P. Suzanne Hart United States 26 337 0.6× 224 0.4× 1.2k 2.2× 420 1.0× 327 0.8× 58 2.3k
Jung‐Wook Kim South Korea 31 899 1.5× 292 0.5× 1.9k 3.5× 357 0.8× 139 0.3× 166 3.0k
Kohji Hara Japan 32 434 0.7× 1.5k 2.7× 497 0.9× 287 0.7× 200 0.5× 107 2.7k
Toshio Sugahara Japan 27 630 1.1× 135 0.2× 829 1.5× 165 0.4× 130 0.3× 121 2.6k

Countries citing papers authored by Hilke Zander

Since Specialization
Citations

This map shows the geographic impact of Hilke Zander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilke Zander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilke Zander more than expected).

Fields of papers citing papers by Hilke Zander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilke Zander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilke Zander. The network helps show where Hilke Zander may publish in the future.

Co-authorship network of co-authors of Hilke Zander

This figure shows the co-authorship network connecting the top 25 collaborators of Hilke Zander. A scholar is included among the top collaborators of Hilke Zander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilke Zander. Hilke Zander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Billingham, Lucinda, Theodor Framke, Alastair Greystoke, et al.. (2023). Histology independent drug development – Is this the future for cancer drugs?. Cancer Treatment Reviews. 123. 102674–102674. 1 indexed citations
2.
Verbaanderd, Ciska, et al.. (2023). Biomarker‐Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union. Clinical Pharmacology & Therapeutics. 114(2). 316–324. 6 indexed citations
3.
Zander, Hilke, et al.. (2020). Checkpointinhibitoren in der Tumortherapie. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(11). 1322–1330. 8 indexed citations
4.
Rothmaier, Markus, et al.. (2015). Acid-coated Textiles (pH 5.5–6.5) – a New Therapeutic Strategy for Atopic Eczema?. Acta Dermato Venereologica. 95(6). 659–663. 16 indexed citations
5.
Ihnen, Maike, Jan Felix Kersten, Ergin Kilic, et al.. (2012). Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. BMC Cancer. 12(1). 140–140. 22 indexed citations
6.
Tachezy, Michael, Hilke Zander, Florian Gebauer, et al.. (2012). Activated leukocyte cell adhesion molecule (CD166)—Its prognostic power for colorectal cancer patients. Journal of Surgical Research. 177(1). e15–e20. 55 indexed citations
7.
Güngör, Cenap, Hilke Zander, Katharina E. Effenberger, et al.. (2011). Notch Signaling Activated by Replication Stress–Induced Expression of Midkine Drives Epithelial–Mesenchymal Transition and Chemoresistance in Pancreatic Cancer. Cancer Research. 71(14). 5009–5019. 117 indexed citations
8.
Gebauer, Florian, Michael Tachezy, Hilke Zander, et al.. (2011). Prognostic Impact of CXCR4 And CXCR7 Expression In Pancreatic Adenocarcinoma. Journal of Surgical Research. 165(2). 176–176. 3 indexed citations
9.
Tachezy, Michael, Katharina E. Effenberger, Hilke Zander, et al.. (2011). ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients. International Journal of Cancer. 131(2). 396–405. 42 indexed citations
10.
Gebauer, Florian, Michael Tachezy, Katharina E. Effenberger, et al.. (2011). Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma. Journal of Surgical Oncology. 104(2). 140–145. 47 indexed citations
11.
Quaas, Alexander, Hilke Zander, Stephanie J. Gros, et al.. (2010). L1 is Highly Expressed in Tumors of the Nervous System: A Study of Over 8000 Human Tissues. Journal of Surgical Research. 173(2). 314–319. 23 indexed citations
12.
Zander, Hilke, et al.. (2007). Biochemical characterization of the recombinant human Nogo‐A ectodomain. FEBS Journal. 274(10). 2603–2613. 11 indexed citations
13.
Breithaupt, Constanze, Anna Schubart, Hilke Zander, et al.. (2003). Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proceedings of the National Academy of Sciences. 100(16). 9446–9451. 105 indexed citations
15.
Polson, Alan M., Sean W. Meitner, & Hilke Zander. (1976). Trauma and progression of marginal periodontitis in squirrel monkeys. Journal of Periodontal Research. 11(5). 290–298. 82 indexed citations
16.
Polson, Alan M., James E. Kennedy, & Hilke Zander. (1974). Trauma and progression of marginal periodontitis in squirrel monkeys. Journal of Periodontal Research. 9(2). 100–107. 25 indexed citations
17.
Zander, Hilke, et al.. (1973). [Psychiatric documentation and information methods. The psychiatric basic documentation. Survey of documentation systems at home and abroad and recommendations of the DGPN for standardization of the criterion catalog].. PubMed. 44(11). 561–8. 1 indexed citations
18.
Zander, Hilke, et al.. (1967). Photogrammetry. The Journal of Periodontology. 38(6P2). 677–681. 7 indexed citations
19.
Zander, Hilke. (1957). Effect of silicate cement and amalgam on the gingiva. The Journal of the American Dental Association. 55(1). 11–15. 51 indexed citations
20.
Halberg, Franz, Paul Albrecht, & Hilke Zander. (1954). Persistence of Eosinophil Rhythm after Splenectomy in Rats.. Experimental Biology and Medicine. 86(2). 404–405. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026